SCHEMBL20006200

SCHEMBL20006200

O=C(c1ccccc1)N1CCC(c2ccccc2)C1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.81
NPC1 O15118 4/20 0.81
ATM Q13315 1/20 0.81
SLC18A3 Q16572 1/20 0.68
SMN1; SMN2 Q16637 3/20 0.65
MAPT P10636 2/20 0.65
ALDH1A1 P00352 2/20 0.64
HPGD P15428 2/20 0.64
LMNA P02545 1/20 0.64
HIF1A Q16665 1/20 0.64
TP53 P04637 1/20 0.61
POLB P06746 1/20 0.61
PARP14 Q460N5 1/20 0.60
PARP10 Q53GL7 1/20 0.60
CA12 O43570 1/20 0.59
CA1 P00915 1/20 0.59
CA2 P00918 1/20 0.59
CA7 P43166 1/20 0.59
CA9 Q16790 1/20 0.59
CA14 Q9ULX7 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12447384 1.00 RAB9A (0.81) RAB9ANPC1ATMSLC18A3SMN1; SMN2
SCHEMBL12447335 0.91 RAB9A (0.72) RAB9ANPC1ATMSLC18A3SMN1; SMN2
SCHEMBL4206605 0.90 CA12 (0.71) RAB9ANPC1ATMSLC18A3ALDH1A1
SCHEMBL4465735 0.90 RAB9A (0.75) RAB9ANPC1ATMSLC18A3SMN1; SMN2
SCHEMBL27860957 0.90 RAB9A (0.71) RAB9ANPC1ATMSLC18A3SMN1; SMN2
SCHEMBL16565829 0.90 RAB9A (0.67) RAB9ANPC1ATMSLC18A3SMN1; SMN2
SCHEMBL13212978 0.90 RAB9A (0.75) RAB9ANPC1ATMSLC18A3SMN1; SMN2
SCHEMBL10720211 0.86 CA12 (0.76) RAB9ANPC1ATMSLC18A3SMN1; SMN2
SCHEMBL23351466 0.85 RAB9A (0.65) RAB9ANPC1ATMSLC18A3SMN1; SMN2
SCHEMBL16712998 0.85 RAB9A (0.68) RAB9ANPC1ATMSLC18A3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018056854-A1 BLOOD-BRAIN BARRIER-PENETRANT DOPAMINE-B-HYDROXYLASE INHIBITORS BIAL - PORTELA & Cª, S.A. (PT) 2018-03-29 WO disclosed